Hyponatremia Management: Core Principles & Bedside Algorithm
Safe Correction of Hyponatremia — 2025 Practical Guideline for Clinicians
1 . Why It Matters
Hyponatremia (Na⁺ < 135 mmol/L) is the most frequent electrolyte disorder on general wards. Mortality doubles when Na⁺ falls below 120 mmol/L, yet >70 % of osmotic demyelination syndrome (ODS) cases are iatrogenic and thus preventable. Current European (2014/2020), American (ASN 2022), and critical-care guidelines all converge on the same message: correct slowly, monitor closely, and use desmopressin as a safety brake. (ese-hormones.org, uptodate.com)
2 . Pathophysiology in a Nutshell
■ Water excess → hypo-osmolar extracellular fluid → cerebral oedema (acute phase). ■ Within ~48 h, neurones extrude osmolytes; thereafter, a rapid rise in tonicity dehydrates myelin → ODS. (evidence.nejm.org)
3 . Clinical Stratification
| Serum Na⁺ (mmol/L) | Typical Symptoms | Immediate Threat |
| 130–134 | Often asymptomatic / subtle cognitive change | Rare |
| 120–129 | Headache, nausea, vomiting, mild confusion, dizziness | Moderate |
| < 120 with seizure/coma/herniation signs | Life-threatening | Yes |
Moderately symptomatic patients without seizures/coma are managed like the middle row, even if Na⁺ < 120.
4 . Five Golden Rules
| # | Rule | Practical Detail |
| 1 | Know chronicity | < 48 h = acute → faster OK; ≥ 48 h = chronic → strictly slow |
| 2 | Targets | +4-6 mmol/L in first 6 h, then ≤ 8 mmol/L/24 h (≤ 6 mmol/L if malnourished, cirrhosis, alcoholism, Na⁺ < 105 mmol/L) (kidneymedicinejournal.org) |
| 3 | Monitor | Serum Na⁺ q 4-6 h (q 2 h on 3 % saline) |
| 4 | Be ready to brake | DDAVP 1-2 µg IV/SC ± D5W if ΔNa⁺ overshoots (amjmed.com) |
| 5 | Correct K⁺ simultaneously | Every 1 mmol rise in K⁺ can raise Na⁺ ≈ 1 mmol/L |
5 . Choosing the Infusion
| Scenario | Fluid | Typical Dose & Rationale |
| Neuro-emergent (seizure/coma) | 3 % NaCl | 100 mL IV over 10 min; repeat ×2 if needed. A 100 mL bolus lifts Na⁺ ~0.9 mmol/L in most adults. (emcrit.org) |
| Moderately symptomatic, hypo- or euvolaemic | 0.9 % NaCl | 1 L at 120 mL/h, re-check Na⁺ at 4 h; may repeat once if ΔNa⁺ < 3 mmol/L and symptoms persist |
| Asymptomatic SIADH | Fluid restriction 800-1000 mL/d ± salt tabs; consider tolvaptan outpatient |
Can I run “0.9 % NaCl 1000 mL @ 120 mL/h × 2” in a Patient with no symptoms such as seizures, altered mental status, coma, and risk of brain herniation, but present only headache, nausea, confusion, and vomiting? Yes—only if the patient matches the moderate-symptom profile and is not hypervolaemic. For a 70 kg adult (TBW ≈ 35 L), each litre of normal saline raises Na⁺ ≈ 1 mmol/L by the Adrogue-Madias equation; two litres give a safe +2 mmol/L. Stop once Na⁺ ↑ 5 mmol/L or symptoms resolve.
6 . Role of Desmopressin (DDAVP)
Indications
- ΔNa⁺ > 8 mmol/L/24 h (or > 6 mmol/L in high-risk brain)
- Rapid aquaresis after loop diuretic or vaptan cessation
- Planned “DDAVP clamp” strategy: 1 µg IV q 8 h with simultaneous hypertonic saline to cap daily riseEvidence supports DDAVP for ODS prevention without increasing ICU length of stay. (sites.duke.edu)
7 . Advanced Clinical Scenarios
| Situation | Nuance | Key Adjustments |
| Thiazide-induced | Auto-correction once drug clears | Stop drug; monitor q 2 h; DDAVP if ΔNa⁺ too fast |
| Cerebral salt wasting (post-SAH) | Hypovolaemic, high urine Na⁺ | 0.9 % or 3 % NaCl + fludrocortisone 0.1 mg BID |
| Marathon hyponatremia | Acute water intoxication | Single 100 mL 3 % bolus; avoid 0.9 % |
| Pregnancy (post-partum) | ↑ ADH clearance | Micro-bolus 3 % (2 mL/kg); limit to +6 mmol/24 h |
| ESKD on HD | Dialysis may over-correct | Use low-Na dialysate 126 mmol/L or controlled 3 % drip |
| Paediatrics | Brain adapts faster, TBW 0.6 | Correct ≤ 6 mmol/24 h; 3 % at 2 mL/kg bolus |
8 . Monitoring & ODS Prevention Checklist
- Na⁺ q 4 h (lab or blood gas electrolyte cartridge)
- K⁺ q 8 h, glucose q 8 h
- Strict I/O; watch for sudden polyuria
- Neuro checks q 2 h (GCS, pupils)
- If ΔNa⁺ exceeds target → DDAVP 2 µg IV + D5W 10 mL/kg to re-lower by 1 mmol/h until back in safe zone
9 . Algorithm at the Bedside
Legend:
HA = Headache
N/V = Nausea/Vomiting
ΔNa⁺ ≤ Goal = Sodium rise within target range (typically ≤ 6-8 mmol/L/day)
DDAVP = Desmopressin (for overcorrection control)
10 . Key Take-Home Messages
- Correct the brain, not the number. +4-6 mmol/L is usually enough to abort symptoms.
- 0.9 % NaCl is safe for neurologically stable patients—even at Na⁺ 117 mmol/L—when hypovolaemia drives the hyponatremia and monitoring is tight.
- ODS is a “never event.” It results from over-correction, not from cautious therapy.
- Desmopressin is your seat-belt. Don’t hesitate to use it.
Master these steps and you will steer patients safely between the Scylla of cerebral oedema and the Charybdis of osmotic demyelination—no locked-in nightmares on your watch.